NCT04682587
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Pfizer New York, United States
Clinical trial condition
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
NCT04682587
NCT04068831
NCT03138512
NCT04028479
NCT01291420
NCT02926053
NCT01693822
NCT03015740
NCT02619253
NCT02639182